» Articles » PMID: 15878974

Prospective Evaluation of 2 Acute Graft-versus-host (GVHD) Grading Systems: a Joint Société Française De Greffe De Moëlle Et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry...

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2005 May 10
PMID 15878974
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

The most commonly used grading system for acute graft-versus-host disease (aGVHD) was introduced 30 years ago by Glucksberg; a revised system was developed by the International Bone Marrow Transplant Registry (IBMTR) in 1997. To prospectively compare the 2 classifications and to evaluate the effect of duration and severity of aGVHD on survival, we conducted a multicenter study of 607 patients receiving T-cell-replete allografts, scored weekly for aGVHD in 18 transplantation centers. Sixty-nine percent of donors were HLA-identical siblings and 28% were unrelated donors. The conditioning regimen included total body irradiation in 442 (73%) patients. The 2 classifications performed similarly in explaining variability in survival by aGVHD grade, although the Glucksberg classification predicted early survival better. There was less physician bias or error in assigning grades with the IBMTR scoring system. With either system, only the maximum observed grade had prognostic significance for survival; neither time of onset nor progression from an initially lower grade of aGVHD was associated with survival once maximum grade was considered. Regardless of scoring system, aGVHD severity accounted for only a small percentage of observed variation in survival. Validity of these results in populations receiving peripheral blood transplants or nonmyeloablative conditioning regimens remains to be tested.

Citing Articles

Mixed T-Cell Chimerism Following Hematopoietic Cell Transplantation for Non-Malignant Disorders Is Common, Facilitates Anti-Viral Immunity, and Is Not Associated with Graft Failure in Pediatric Patients.

Nadaf R, Lee H, Bonney D, Hanasoge-Nataraj R, Senthil S, Horgan C Cells. 2025; 13(24.

PMID: 39768209 PMC: 11727161. DOI: 10.3390/cells13242119.


Targeting T cells with tetravalent bispecific antibodies for the treatment of graft-versus-host disease.

Espinosa-Cotton M, Hoseini S, Miranda I, Herrick J, Cheung N Blood Adv. 2024; 9(1):116-126.

PMID: 39293079 PMC: 11742559. DOI: 10.1182/bloodadvances.2022009187.


Intestinal and Extraintestinal Findings of Graft-versus-Host Disease on CT: A Case Series with Radiological and Histopathological Correlations.

Brogna B, Frieri C, Risitiano A, Urciuoli L, Storti G, Santoro L Biomedicines. 2024; 12(7).

PMID: 39062089 PMC: 11275234. DOI: 10.3390/biomedicines12071516.


Novel MAGIC composite scores using both clinical symptoms and biomarkers best predict treatment outcomes of acute GVHD.

Akahoshi Y, Spyrou N, Weber D, Aguayo-Hiraldo P, Ayuk F, Chanswangphuwana C Blood. 2024; 144(9):1010-1021.

PMID: 38968143 PMC: 11830971. DOI: 10.1182/blood.2024025106.


Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis.

Denk A, Edinger M, Weber D, Holler E, Fante M, Meedt E Ann Hematol. 2024; 103(8):3071-3081.

PMID: 38916740 PMC: 11283387. DOI: 10.1007/s00277-024-05696-x.


References
1.
MacMillan M, Weisdorf D, Wagner J, DeFor T, Burns L, Ramsay N . Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems. Biol Blood Marrow Transplant. 2002; 8(7):387-94. DOI: 10.1053/bbmt.2002.v8.pm12171485. View

2.
Antin J, Weisdorf D, Neuberg D, Nicklow R, Clouthier S, Lee S . Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation. Blood. 2002; 100(10):3479-82. DOI: 10.1182/blood-2002-03-0985. View

3.
Weisdorf D, Hurd D, Carter S, Howe C, Jensen L, Wagner J . Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review. Biol Blood Marrow Transplant. 2003; 9(8):512-8. DOI: 10.1016/s1083-8791(03)00162-9. View

4.
Graf E, Schmoor C, Sauerbrei W, Schumacher M . Assessment and comparison of prognostic classification schemes for survival data. Stat Med. 1999; 18(17-18):2529-45. DOI: 10.1002/(sici)1097-0258(19990915/30)18:17/18<2529::aid-sim274>3.0.co;2-5. View

5.
Przepiorka D, Weisdorf D, MARTIN P, Klingemann H, Beatty P, Hows J . 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995; 15(6):825-8. View